These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16856256)

  • 1. [PET?: comfortable whole body checkup].
    Hanafusa K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jun; 62(6):781-5. PubMed ID: 16856256
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid whole body
    Yang M; Zhou Y; Hoxworth JM; Porter AB; Roarke MC
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):261-263. PubMed ID: 28803890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Positron emission tomography/computed tomography with 18F-FDG. PET Working Group. Procedures Committee of the Spanish Society of Nuclear Medicine].
    García Garzón JR; Rodríguez A; Cabrera A
    Rev Esp Med Nucl; 2009; 28(2):85-9. PubMed ID: 19406058
    [No Abstract]   [Full Text] [Related]  

  • 4. Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT?
    Kwee TC
    Lancet Oncol; 2014 Mar; 15(3):243-4. PubMed ID: 24559804
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical application of positron emission tomography and 18FDG to brain tumor].
    Momose T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
    [No Abstract]   [Full Text] [Related]  

  • 6. Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan.
    Lyall A; Capobianco J; Strauss HW; Gonen M; Schöder H
    J Nucl Med; 2012 Jun; 53(6):917-21. PubMed ID: 22586146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET/CT scans for children and adolescents.
    Lassmann M; Eberlein U; Tosi G; Chiti A
    Lancet Oncol; 2014 Jun; 15(7):e243-4. PubMed ID: 24872098
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG PET/CT scans for children and adolescents - authors' reply.
    Daldrup-Link H; Quon A; Goske M
    Lancet Oncol; 2014 Jun; 15(7):e244. PubMed ID: 24872100
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[Practice guidelines for FDG PET, PET/CT].
    Japanese Society of Nuclear Medicine
    Kaku Igaku; 2010 May; 47(2):153-62. PubMed ID: 22462155
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult-onset Still disease: evaluation with serial f-18 fluorodeoxyglucose positron emission tomography.
    Vranken E; Versijpt J; Winne L; Veys EM; Hamphrey H
    Clin Nucl Med; 2005 Nov; 30(11):740-1. PubMed ID: 16237300
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
    Sanz-Viedma S; Torigian DA; Parsons M; Basu S; Alavi A
    Rev Esp Med Nucl; 2009; 28(3):159-66. PubMed ID: 19558958
    [No Abstract]   [Full Text] [Related]  

  • 15. F-18 FDG PET superscan.
    Su HY; Liu RS; Liao SQ; Wang SJ
    Clin Nucl Med; 2006 Jan; 31(1):28-9. PubMed ID: 16374120
    [No Abstract]   [Full Text] [Related]  

  • 16. Sigmoid colon metastasis from metaplastic breast carcinoma mimicking primary sigmoid colon cancer.
    Kim HW; Moon DH
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):211-2. PubMed ID: 25448418
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
    Shiue CY; Welch MJ
    Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
    Kawata S; Imaizumi M; Kako Y; Oku N
    Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET imaging of subependymal gray matter heterotopia.
    Conrad GR; Sinha P
    Clin Nucl Med; 2005 Jan; 30(1):35-6. PubMed ID: 15604968
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality control of PET imaging: from study to diagnosis].
    Daisaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.